Onvansertib Cancer Therapy Presentation December 2021

Investor presentation for Onvansertib, a precision medicine therapeutic candidate, highlighting the company's management team and clinical development strategy. The deck outlines the company's approach to turning the tide on cancer through novel drug development and biomarker technology expertise.